Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Predictive Oncology Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
POAI
Nasdaq
3841
https://predictive-oncology.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Predictive Oncology Inc
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Apr 24th, 2024 8:05 pm
Predictive Oncology Inc. (NASDAQ:POAI) Q4 2023 Earnings Call Transcript
- Apr 2nd, 2024 2:31 pm
Predictive Oncology Full Year 2023 Earnings: US$3.48 loss per share (vs US$7.05 loss in FY 2022)
- Mar 31st, 2024 2:12 pm
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update
- Mar 28th, 2024 9:28 pm
Predictive Oncology to Participate in Upcoming Investor Conferences
- Feb 21st, 2024 9:05 pm
Predictive Oncology to Participate in Upcoming San Francisco Conferences
- Jan 2nd, 2024 12:00 pm
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
- Nov 14th, 2023 12:00 pm
Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital
- Nov 8th, 2023 1:12 pm
Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023
- Nov 7th, 2023 12:00 pm
Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update
- Aug 10th, 2023 9:15 pm
Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023
- Aug 3rd, 2023 12:00 pm
Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh
- Jul 18th, 2023 12:00 pm
Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board
- Jun 27th, 2023 12:00 pm
Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board
- Jun 20th, 2023 12:00 pm
Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention
- May 23rd, 2023 12:30 pm
Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business Update
- May 15th, 2023 9:15 pm
Predictive Oncology to Report First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 15, 2023
- May 8th, 2023 12:00 pm
Predictive Oncology Appoints Pharma, Biotech and Digital Health Veteran Veena Rao, PhD, MBA, to its Board of Directors
- May 2nd, 2023 9:10 pm
Scroll